These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28069290)

  • 41. Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.
    Leifer I; Lange E; Reimann I; Blome S; Juanola S; Duran JP; Beer M
    Vaccine; 2009 Nov; 27(47):6522-9. PubMed ID: 19732859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections.
    Yang Z; Wu R; Li RW; Li L; Xiong Z; Zhao H; Guo D; Pan Z
    Virus Res; 2012 Apr; 165(1):61-70. PubMed ID: 22285514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First assessment of classical swine fever marker vaccine candidate CP7_E2alf for oral immunization of wild boar under field conditions.
    Feliziani F; Blome S; Petrini S; Giammarioli M; Iscaro C; Severi G; Convito L; Pietschmann J; Beer M; De Mia GM
    Vaccine; 2014 Apr; 32(18):2050-5. PubMed ID: 24565752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Piglets with maternally derived antibodies from sows immunized with rAdV-SFV-E2 were completely protected against lethal CSFV challenge.
    Xia SL; Du M; Lei JL; Liu Y; Wang Y; Ji S; Xiang GT; Li LF; Cong X; Luo Y; Shao L; Qiu HJ; Sun Y
    Vet Microbiol; 2016 Jul; 190():38-42. PubMed ID: 27283854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccination against classical swine fever virus: limitations and new strategies.
    Greiser-Wilke I; Moennig V
    Anim Health Res Rev; 2004 Dec; 5(2):223-6. PubMed ID: 15984328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs.
    Tignon M; Kulcsár G; Haegeman A; Barna T; Fábián K; Lévai R; Van der Stede Y; Farsang A; Vrancken R; Belák K; Koenen F
    Vet Microbiol; 2010 Apr; 142(1-2):59-68. PubMed ID: 19857935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology, diagnosis and control of classical swine fever: Recent developments and future challenges.
    Postel A; Austermann-Busch S; Petrov A; Moennig V; Becher P
    Transbound Emerg Dis; 2018 May; 65 Suppl 1():248-261. PubMed ID: 28795533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel marker vaccines against classical swine fever.
    Beer M; Reimann I; Hoffmann B; Depner K
    Vaccine; 2007 Jul; 25(30):5665-70. PubMed ID: 17239502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protection of pigs from lethal challenge by a DNA vaccine based on an alphavirus replicon expressing the E2 glycoprotein of classical swine fever virus.
    Li N; Zhao JJ; Zhao HP; Sun Y; Zhu QH; Tong GZ; Qiu HJ
    J Virol Methods; 2007 Sep; 144(1-2):73-8. PubMed ID: 17499369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of an improved live attenuated antigenic marker CSF vaccine strain candidate with an increased genetic stability.
    Holinka LG; Fernandez-Sainz I; Sanford B; O'Donnell V; Gladue DP; Carlson J; Lu Z; Risatti GR; Borca MV
    Virology; 2014 Dec; 471-473():13-8. PubMed ID: 25461526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunity.
    Gabriel C; Blome S; Urniza A; Juanola S; Koenen F; Beer M
    Vaccine; 2012 Apr; 30(19):2928-36. PubMed ID: 22406108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective efficacy of a Classical swine fever virus C-strain deletion mutant and ability to differentiate infected from vaccinated animals.
    Kortekaas J; Ketelaar J; Vloet RP; Loeffen WL
    Vet Microbiol; 2011 Jan; 147(1-2):11-8. PubMed ID: 20541334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows.
    Depner KR; Bouma A; Koenen F; Klinkenberg D; Lange E; de Smit H; Vanderhallen H
    Vet Microbiol; 2001 Nov; 83(2):107-20. PubMed ID: 11557152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chimeric Pestivirus Experimental Vaccines.
    Reimann I; Blome S; Beer M
    Methods Mol Biol; 2016; 1349():239-46. PubMed ID: 26458840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigation of chronic and persistent classical swine fever infections under field conditions and their impact on vaccine efficacy.
    Coronado L; Bohórquez JA; Muñoz-González S; Perez LJ; Rosell R; Fonseca O; Delgado L; Perera CL; Frías MT; Ganges L
    BMC Vet Res; 2019 Jul; 15(1):247. PubMed ID: 31307464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Oral Bait Vaccine Efficacy Against Classical Swine Fever in Village Backyard Pig Farms in Bhutan.
    Monger VR; Stegeman JA; Dukpa K; Gurung RB; Loeffen WL
    Transbound Emerg Dis; 2016 Dec; 63(6):e211-e218. PubMed ID: 25660486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy evaluation of the C-strain-based vaccines against the subgenotype 2.1d classical swine fever virus emerging in China.
    Luo Y; Ji S; Lei JL; Xiang GT; Liu Y; Gao Y; Meng XY; Zheng G; Zhang EY; Wang Y; Du ML; Li Y; Li S; He XJ; Sun Y; Qiu HJ
    Vet Microbiol; 2017 Mar; 201():154-161. PubMed ID: 28284603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of the efficacy of an attenuated live marker classical swine fever vaccine (Flc-LOM-BE
    Lim SI; Choe S; Kim KS; Jeoung HY; Cha RM; Park GS; Shin J; Park GN; Cho IS; Song JY; Hyun BH; Park BK; An DJ
    Vaccine; 2019 Jun; 37(27):3598-3604. PubMed ID: 31151802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
    Zhao HP; Sun JF; Li N; Sun Y; Wang Y; Qiu HJ
    Vet Immunol Immunopathol; 2009 Oct; 131(3-4):158-66. PubMed ID: 19411115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs.
    Dewulf J; Laevens H; Koenen F; Mintiens K; de Kruif A
    Prev Vet Med; 2004 Oct; 65(3-4):121-33. PubMed ID: 15488266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.